Quantcast

US Drug Watchdog Now Urges All Victims Of The Transvaginal Mesh Failure To Call Them For The Names Of National Caliber Attorneys–Who Are All Women-Don’t Get Shortchanged

September 21, 2012

Because a transvaginal mesh failure can be such a complicated and very delicate issue for a woman victim the US Drug Watchdog has designed their Transvaginal Mesh Victims Initiative around the core concept that women victims will get access to the highest caliber national attorneys-who are all women. The US Drug Watchdog does not believe a woman victim of a transvaginal mesh failure would want to share this type of information with a male attorney. As a background the transvaginal mesh products were designed for women, who were suffering from pelvic organ prolapse, and or stress urinary incontinence. The procedure to install a transvaginal mesh was supposed to be minimally-invasive. The US FDA is now saying transvaginal mesh failures are causing complications in patients such as erosion and infection. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries, IV therapy, blood transfusions and drainage of hematomas or abscesses.” The US Drug Watchdog is now expanding their national initiative designed to help women recipients of transvaginal mesh, that is also called a sling, who are now severely injured by these types of medical products. For more information women, who are victims of a transvaginal mesh failure are urged to contact the US Drug Watchdog anytime at 866-714-6466. http://USDrugWatchdog.Com

(PRWEB) September 21, 2012

The US Drug Watchdog intends to dramatically grow their national initiative focused on helping women recipients of a failed transvaginal mesh, also known as a sling, because there could easily be thousands of victims. Just to be clear on the scope and potential size of transvaginal mesh failures, according to the New York Times, “In 2010, about 185,000 US women underwent procedures in which mesh was implanted vaginally to treat urinary incontinence.” The US Drug Watchdog says, “Transvaginal mesh or Bladder Sling failure occurs when the mesh fails to bind to a woman’s pelvic tissues. As a consequence of this, the body rejects the mesh that has been sewn into it. As a result, the transvaginal mesh may start to poke its way through the vaginal wall and protrude out of the vaginal tissue. This complication is more commonly referred to as erosion. Erosion may result in extreme pain, infection, bleeding, vaginal discharge, and no possibility for sexual intercourse.” The US Drug Watchdog’s national initiative is designed to assist any women in the US, who is a victim of a transvaginal mesh, or bladder sling failure, and the group will provide all women victims with the specific contacts of national caliber attorneys-who are all women. For more information women, who are now victims of a transvaginal mesh failure are urged to call the US Drug Watchdog anytime at 8660714-6466. http://USDrugWatchdog.Com

The US Drug Watchdog is indicating symptoms of a transvaginal mesh/Sling implant failure may include:

  • Pain during sexual intercourse caused by erosion.
  • Mesh erosion through the vagina (the mesh is actually protruding out of the vaginal wall)
  • Bleeding
  • Vaginal Infection
  • Urinary problems
  • Organ perforation
  • Hardening of the vaginal mesh
  • Injury to nearby organs
  • Severe Pelvic Pain

The US Drug Watchdog says, “One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like a transvaginal mesh failure. If you have a friend, or loved one who is a recipient of a transvaginal mesh product that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. We want to make certain all women, who are transvaginal mesh failure victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women.” http://USDrugWatchdog.Com

U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:

C.R. Bard, Inc., (MDL No. 2187);

American Medical Systems Inc., MDL No. 2325);

Boston Scientific Corp., (MDL No. 2326); and Ethicon, Inc. (MDL No. 2327)

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9907551.htm


Source: prweb



comments powered by Disqus